170236-39-2

Basic information

• Product Name: N-[9-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxytetrahydrofuran-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
• Synonyms: N-[9-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxytetrahydrofuran-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
• CAS NO: 170236-39-2
• Molecular Weight: 639.708
• Mol File: 170236-39-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-[9-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxytetrahydrofuran-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[9-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxytetrahydrofuran-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide(170236-39-2)
• EPA Substance Registry System: N-[9-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxytetrahydrofuran-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide(170236-39-2)

Safety Data

• Hazardous Substances Data: 170236-39-2(Hazardous Substances Data)

Upstream product

• 87865-78-9 3',5'-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl)-N₂-isobutyrylguanosine 
• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 121513-00-6 3-O-benzoyl-2-desoxyxyloguanosine 
• 170236-40-5 5'-O-(4,4-dimethoxytriphenyl)methyl-N-2-isobutyryl-3'-O-benzoyl-2'-desoxyxyloguanosine 
• 121513-00-6 [(2R,3R,5R)-2-(hydroxymethyl)-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]tetrahydrofuran-3-yl] benzoate 
• 104769-15-5 [(2R,3S,5R)-3-hydroxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]tetrahydrofuran-2-yl]methyl benzoate 
• 825638-98-0 C₃₅H₃₅N₅O₇ 
• 719288-75-2 5'-dimethoxytrityl-2'-tosyl-N₂-isobutyrylguanosine 
• 719288-76-3 Methanesulfonic acid (2R,3R,4R,5R)-5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-2-(2-isobutyrylamino-6-oxo-1,6-dihydro-purin-9-yl)-tetrahydro-furan-3-yl ester 
• 170236-40-5 [(2R,3R,5R)-2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-5-[2-(2-methylpropanoylamino)-6-oxo- 1H-purin-9-yl]tetrahydrofuran-3-yl] benzoate 
• 1187644-19-4 3'-O(R)-(methylsulfonyl)-N₂-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine 
• 961-07-9 2'-Deoxyguanosine 
• 68892-41-1 5'-O-dimethoxytrityl-N-isobutyryldeoxyguanosine 
• 68892-42-2 N-isobutyryl-2'-deoxyguanosine 

Downstream Products

• 170236-41-6 3'-azido-5'-O-(4,4'-dimethoxytrityl)-N₂-isobutyryl-2',3'-dideoxyguanosine 
• 934980-57-1 N²-isobutyryl-5'-(4,4'-dimethoxytrityl)-3'-S-benzoyl-2',3'-dideoxy-3'-thioguanosine 
• 1421632-81-6 N₂-isobutyryl-5'-O-dimethoxytrityl-2'-deoxy-3'-thioguanosine 
• 1421632-82-7 N₂-isobutyryl-5'-O-dimethoxytrityl-2'-deoxy-3'-thio-guanosine-3'-S-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite 
• 1609117-77-2 3-S-acetyl-5-O-(4,4-dimethoxytriphenyl)methyl-N-2-isobutyryl-3-thio-2-3-didesoxyguanosine 
• 1421632-81-6 5-O-(4,4-dimethoxytriphenyl)methyl-N-2-isobutyryl-3-thio-2-3-didesoxyguanosine 

Relevant articles and documents

MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

The present disclosure provides oligomeric compounds comprising a modified oligonucleotide having at least one stereo-non-standard nucleoside. An oligomeric compound comprising a modified oligonucleotide consisting of 12-30 linked nucleosides, wherein at least one nucleoside of the modified oligonucleotide is a stereo-non-standard nucleoside; and wherein the oligomeric compound is selected from among an RNAi compound, a modified CRISPR compound, and an artificial mRNA compound.

DNA with 3′-5′-disulfide links - Rapid chemical ligation through isosteric replacement

Efforts to chemically ligate oligonucleotides, without resorting to biochemical enzymes, have led to a multitude of synthetic analogues, and have extended oligomer ligation to reactions of novel oligonucleotides, peptides, and hybrids such as PNA.1 Key re

COMPOUNDS FOR TREATING BACTERIAL INFECTIONS

The present invention relates to a novel class of guanine nucleotide analogs which inhibit RelA and Relseq synthetic activity and which possess anti-bacterial activity. The present invention also relates to pharmaceutical compositions that include such compounds, and to methods of use of such compounds or compositions for combating bacteria and treating bacterial infections.